baber/WOPTO huggingface dataset:
Patent MY-134825-A (MY)
Title: Test emulator, test module emulator, and record medium storing program therein
Inventor: HIGASHI SHINSAKU
IPC: G01R31/3183
Filed: 2004-03-30
Abstract: THERE IS PROVIDED A TEST EMULATOR (190) FOR EMULATING A TEST APPARATUS (10) INCLUDING A PLURALITY OF TEST MODULES (170) FOR SUPPLYING TEST SIGNAL TO DEVICES UNDER TEST (100) RESPECTIVELY, INCLUDING: A PLURALITY OF TEST MODULE EMULATION SECTIONS (270) FOR EMULATING THE PLURALITY OF TEST MODULES (170) GENERATING THE TEST SIGNAL BASED ON DIFFERENT CYCLES, A CONTROL EMULATION SECTION (230) FOR EMULATING A CONTROL APPARATUS FOR CONTROLLING THE TEST OF THE DEVICES UNDER TEST (100), A SYNCHRONOUS EMULATION SECTION (250) FOR GENERATING TEST SIGNAL GENERATING TIMINGS, AT WHICH EACH OF THE PLURALITY OF TEST MODULE EMULATION SECTIONS (270) IS TO GENERATE THE TEST SIGNAL IN SIMULATION CORRESPONDING TO CYCLE TIME OF THE TEST MODULE EMULATION SECTION (270), BASED ON INSTRUCTIONS FROM THE CONTROL EMULATION SECTION (230), A TIMING ALIGNMENT SECTION (276) FOR ALIGNING THE PLURALITY OF TEST SIGNAL GENERATING TIMINGS GENERATED BY THE SYNCHRONOUS EMULATION SECTION (250) IN ORDER OF TIME, AND OUTPUTTING THEM ONE BY ONE, AND A SCHEDULE SECTION (277) FOR CAUSING THE TEST MODULE EMULATION SECTION (270) CORRESPONDING TO ONE OF THE TEST SIGNAL GENERATING TIMINGS OUTPUT BY THE TIMING ALIGNMENT SECTION (276) TO GENERATE THE TEST SIGNAL IN SIMULATION IN THE CYCLE TIME CORRESPONDING TO THE TEST SIGNAL GENERATING TIMING.FIG.2
Patent MY-137904-A (MY)
Title: Detection of errors
Inventor: LESARTRE GREGG BERNARD
IPC: H03M13/00
Filed: 2004-07-21
Abstract: A DATA COMMUNICATIONS ARCHITECTURE (200) EMPLOYING SERIALIZERS (300-1) AND DESERIALIZERS (400-1) THAT REDUCES DATA COMMUNICATIONS LATENCY. IN AN ILLUSTRATIVE IMPLEMENTATION, THE DATA COMMUNICATIONS ARCHITECTURE (200) COMMUNICATES DATA (230) ACROSS COMMUNICATIONS LINKS. THE ARCHITECTURE MAINTAINS VARIOUS MECHANISMS TO PROMOTE DATA COMMUNICATIONS SPEED AND TO AVOID COMMUNICATION LINK (215) DOWN TIME. THESE MECHANISMS PERFORM THE FUNCTIONS INCLUDING BUT NOT LIMITED TO HANDLING UNCERTAIN DATA ARRIVAL TIMES, DETECTING SINGLE BIT AND MULTI-BIT ERRORS, HANDLING COMMUNICATIONS LINK FAILURES, ADDRESSING FAILED LINK TRAINING, IDENTIFYING AND MARKING DATA AS CORRUPT, AND IDENTIFYING AND PROCESSING SUCCESSFUL DATA TRANSACTIONS ACROSS THE COMMUNICATIONS LINK.FIGURE 1
Patent MY-138168-A (MY)
Title: Compressor
Inventor: KISHI YASUHIRO
IPC: F04C18/356
Filed: 2004-10-21
Abstract: IN ORDER TO REDUCE LEKAGE OF A REFRIGERENT CAUSED BY CHANGES IN PRESSURE DIFFERENCES BETWEEN COMPRESSION ELEMENTS AND ACHIVE AN INCREASE IN VOLUMETRIC EFFICIENTCY AND COMPRESSOR EFFICIENTCY OF A TWO STAGE COMPRESSOR, A ROTARY TYPE TWO STAGE COMPRESSOR COMPRISES AN ELECTIC MOTOR RECEIVED INA CLOSED VESSEL, ROTATING COMPRESSION ELEMENTS PROVIDED BY STACKING A LOW-PRESSURE COMPRESSION ELEMENT AND A HIGH-PRESSURE COMPRESSION ELEMENT IN A LAMINATED MANNER, AND A SUB-BEARING SUPPORTING A ROTATING SHAFT, AND WHEREIN EACH OF THE LOW-PRESSURE COMPRESSION ELEMENT AND THE HIGH-PRESSURE COMPRESSION ELEMENT COMPRISES A CYLINDRICAL-SHAPED CYLINDER, A CYLINDRICAL-SHAPED ROLLER REVOLVING ECCENTRICALLY ALONG AN INNER WALL OF THE CYLINDER, AND A VANE IN THE FORM OF A FLAT PLATE TO DIVIDE A SPACE DEFINED BY AN OUTER PERIPHERY OF THE ROLLER AND THE INNER WALL OF THE CYLINDER, AND AN ANGLE BETWEEN THE VANE OF THE LOW-PRESSURE COMPRESSION ELEMENT AND A POSITION, IN WHICH A CLEARANCE BETWEEN THE INNER WALL OF THE CYLINDER AND AN OUTER PERIPHERY OF THE ROLLER BECOMES MINIMUM, IS SET TO RANGE FROM 150° TO 210°.
Patent MY-142090-A (MY)
Title: Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists
Inventor: JANSSENS FRANS EDUARD
IPC: A61P29/00
Filed: 2005-04-04
Abstract: THIS INVENTION CONCERNS SUBSTITUTED DIAZA-SPIRO-[5.5]-UNDECANE DERIVATIVES HAVING NEUROKININ ANTAGONISTIC ACTIVITY, IN PARTICULAR NK₁ ANTAGONISTIC ACTIVITY,A COMBINED NK₁/NK₂ ANTAGONISTIC ACTIVITY, A COMBINED NK₁/NK₃ ANTAGONISTIC ACTIVITY AND A COMBINED NK₁/NK₂/NK₃ ANTAGONISTIC ACTIVITY, THIER PREPARATION, COMPOSITIONS COMPRISING THEM AND THEIR USE AS A MEDICINE, IN PARTICULAR FOR THE TREATMENT AND/OR PROPHYLAXIS OF SCHIZOPHRENIA, EMESIS, ANXIETY AND DEPRESSION, IRRITABLE BOWEL SYNDROME (IBS), CIRACADIAN RHYTHM DISTURBANCES, PRE-ECLAMPSIA, NOCICEPTION, PAIN, IN PARTICULAR VISCERAL AND NEURAOPHATIC PAIN, PANCREATITIS, NEUROGENIC INFLAMMATION, ASTHMA, COPD AND MICTURITION DISORDERS SUCH AS URINARY INCONTINENCE. THE COMPOUNDS ACCORDING TO THE INVENTION CAN BE REPRESENTED BY GENERAL FORMULA (1) AND COMPRISES ALSO THE PHARMACEUTICALLY ACCEPTABLE ACID OR BASE ADDITION SALTS THEREOF, THE STREOCHEMICALLY ISOMERIC FORMS THEREOF, THE N-OXIDE FORM THEREOF AND PRODRUGS THEREOF, WHEREIN ALL SUBSTITUENTS ARE DEFINED AS IN CLAIM 1.
Patent MY-142383-A (MY)
Title: Palm- based biodiesel formulation
Inventor: MAY CHOO YUEN DR
IPC: C10L1/00
Filed: 2005-06-10
Abstract: PALM-BASED BIODIESEL FORMULATIONS WITH ENHANCED COLD FLOW PROPERTIES ARE PROVIDED INCLUDING THE FOLLOWING: (I) A BIODIESEL FORMULATION COMPRISING NOT MORE THAN 40 VOL % PALM-BASED BIODIESEL AND NOT LESS THAN 60 VOL % PETROLEUM-BASED FUEL OIL; (II) A BIODIESEL FORMULATION COMPRISING NOT MORE THAN 20 WT % PALM-BASED BIODIESEL AND NOT LESS THAN 80 WT % ALKYL ESTER OF C6 - CI8 SATURATED OR UNSATURATED FATTY ACID, OR A MIXTURE THEREOF, WHEREIN THE ALKYL ESTER IS METHYL, ETHYL, ISOPROPYL, N-BUTYL, 2-BUTYL OR ISOBUTYL ESTER, OR A MIXTURE THEREOF; (ILL) A BIODIESEL FORMULATION COMPRISING APPROXIMATELY 0.1 - 1.0 % (WT/VOL) OF A POLYLKYL METHACRYLATE (P AMA) ADDITIVE AND A PALM-BASED BIODIESEL BLEND COMPRISING I) NOT MORE THAN 40 VOL % PALM-BASED BIODIESEL; AND II) NOT LESS THAN 60 VOL % PETROLEUM-BASED FUEL OIL; (IV) A BIODIESEL FORMULATION COMPRISING APPROXIMATELY 0.1 - 5.0 % (WT/VOL) OF A POLYLKYL METHACRYLATE (P AMA) ADDITIVE AND A PALM-BASED BIODIESEL HAVING UNSATURATION LEVEL OF NOT LESS THAN 60 %.
Patent MY-141874-A (MY)
Title: Vaccine formulations comprising an oil-in-water emulsion
Inventor: ANDRE PARISOT ALEXIS GUY
IPC: A61K39/39
Filed: 2006-01-27
Abstract: THE PRESENT INVENTION PROVIDES FOR A NOVEL OIL-IN-WATER (O/W) EMULSION, WITH INCREASED STABILITY IN THE PRESENCE OF BACTERIAL OR VIRAL SUSPENSIONS, ESPECIALLY THOSE CONCENTRATED AND NON-PURIFIED OR WEAKLY PURIFIED. THE EMULSION OF THE PRESENT INVENTION CAN ACT AS VEHICLE FOR THE DELIVERY OF A PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE IMMUNOGEN AND, IN PARTICULAR, AN IMMUNOGEN SELECTED FORM THE GROUP COMPRISING AN INACTIVATED PATHOGEN, AN ATTENUATED PATHOGEN, A SUBUNIT, A RECOMBINANT EXPRESSION VECTOR, AND A PLASMID OR COMBINATIONS THEREOF. IN ONE EMBODIMENT, THE PRESENT INVENTION PROVIDES FOR AN INJECTABLE OIL-IN-WATER (O/W) EMULSION COMPRISING: (1) AN AQUEOUS SOLUTION CONTAINING AN IMMUNOGEN, SAID IMMUNOGEN SELECTED FROM THE GROUP COMPRISING AN INACTIVATED MYCOPLASMA HYOPNEUMONIAE BACTERIUM, AN INACTIVATED D PORCINE CIRCOVIRUS TYPE 2 (PCV-2) VIRUS OR COMBINATIONS THEREOF; (2) A MINERAL OIL; (3) A NON-IONIC LIPOPHILIC SURFACTANT; AND (4) A NON-IONIC HYDROPHILIC SURFACTANT HAVING A LOW HLB VALUE WHICH COMPRISES ETHOXYLATED FATTY ACID DIESTERS OF SORBITAN (GENERALLY HAVING HLB VALUE BETWEEN 11 AND 13).
Patent MY-146240-A (MY)
Title: Oral composition containing non-aggregated zinc nanoparticles
Inventor: BOYD THOMAS J
IPC: A61K8/27
Filed: 2006-07-20
Abstract: AN ORAL COMPOSITION COMPRISING A VEHICLE AND A ZINC ION SOURCE IN THE FORM OF NANOPARTICLES THAT ARE SUBSTANTIALLY NON-AGGREGATED AND METHODS FOR USE OF SUCH COMPSOTIONS ARE DESCRIBED. THE COMPOSITION PROVIDES ANTIPLAQUE AND ANTI MALODOR BENEFITS TO THE USER AND THE INCLUSION OF NANOPARTICLES PERMITS A REDUCTION IN THE AMOUNT OF ZINC IONS PRESENT IN THE COMPOSITION WHILE MAINTAINING EFFICACY.
Patent MY-147106-A (MY)
Title: Method for manufacturing epitaxial wafer
Inventor: SAKAE KOYATA
IPC: H01L27/115
Filed: 2007-01-24
Abstract: A METHOD FOR MANUFACTURING AN EPITAXIAL WAFER THAT CAN REDUCE OCCURRENCE OF A SURFACE DEFECT OR A SLIP FORMED ON AN EPITAXIAL LAYER IS PROVIDED. THE MANUFACTURING METHOD IS CHARACTERIZED BY COMPRISING: A SMOOTHING STEP (12) OF CONTROLLING APPLICATION OF AN ETCHANT TO A WAFER SURFACE IN ACCORDANCE WITH A SURFACE SHAPE OF A SILICON WAFER (21) TO SMOOTH THE WAFER SURFACE; AND AN EPITAXIAL LAYER FORMING STEP (13) OF FORMING AN EPITAXIAL LAYER FORMED OF A SILICON SINGLE CRYSTAL ON THE SURFACE OF THE WAFER (21) BASED ON EPITAXIAL GROWTH.
Patent MY-140909-A (MY)
Title: Produce treatment method
Inventor: LIONEL SCOTT
IPC: A23L5/30
Filed: 2007-04-10
Abstract: 19 PRODUCE TREATMENT METHOD ABSTRACT A METHOD FOR STORING FRESH PRODUCE AND COMESTIBLE DERIVATIVES THEREOF WHILE CONTROLLING THE TOTAL VIABILITY COUNT ARID/OR SURFACE PATHOGEN COUNT THEREON COMPRISES THE STEP OF SHINING LIGHT 5 WAVELENGTHS SELECTED FROM BLUE LIGHT, RED LIGHT OR A COMBINATION OF RED LIGHT AND BLUE LIGHT ONTO THE SURFACE OF THE PRODUCE -
Patent MY-147454-A (MY)
Title: Means for controlling the progression of myopia
Inventor: ANTHONY HOLDEN BRIEN
IPC: G02C7/04
Filed: 2008-12-05
Abstract: MEEANS FOR CONTROLLING THE PROGRESSION OF MYOPIA 5 A CONTACT LENS (10) FOR USE IN CONTROLLING OR RETARDING THE PROGRESSION OF MYOPIA IN AN EYE HAS A CENTRAL OPTICAL ZONE (20) APPROXIMATIN THE NORMAL DIAMETER OF THE PUPIL OF THE EYE . 9 (22) THAT GIVES CLEAR CENTRAL VISION AT DISTANCE FOR THE WEARER. AN ANNULAR PERIPHERAL OPTICAL ZONE 24 THAT IS SUBSTANTIALLY OUTSIDE THE DIAMETER OF THE PUPIL IS FORMED AROUND THE CENTRAL OPTICAL ZONE (20) WITH GREATER REFRACTIVE POWER THAN THAT OF THE CENTRAL ZONE (22) IO SO THAT OBLIQUE RAYS ENTERING THE EYE THROUGH THE PERIPHERAL OPTICAL ZONE (24) WILL BE BROUGHT TO FOCUS AT A FOCAL PLANE THAT IS SUBSTANTIALLY ON OR ANTERIOR TO THE PERIPHERAL REGION OF THE RETINA. PREFERABLY, THE REAR SURFACE (16) OF THE LENS IS SHAPED TO CONFORM TO THE CORNEA OF THE EYE AND THE FRONT SURFACE (I 8) OF THE LENS (10) IS SHAPED TO PROVIDE - IN CONJUNCTION WITH THE REAR SURFACE (I 6) - THE DESIRED OPTICAL PROPERTIES OF THE CENTRAL AND 15 PERIPHERAL OPTICAL ZONES. THE FRONT SURFACE (I 8) IS ALSO PREFERABLY CONTOURED TO FORM A SMOOTH TRANSITION (30) BETWEEN THE JUNCTION OF THE CENTRAL OPTICAL ZONE (20) AND THE PERIPHERAL OPTICAL ZONE (24), WITH OR WITHOUT DESIGNED OPTICAL PROPERFIES SUCH AS PROGRESSIVE POWER. 20
Patent MY-143929-A (MY)
Title: Method and system for interworking of cellular networks and wireless local area networks
Inventor: SHAHEEN KAMEL M
IPC: H04W36/14
Filed: 2005-12-07
Abstract: A METHOD AND SYSTEM FOR INTERWORKING BETWEEN CELLULAR NETWORKS AND WIRELESS LOCAL AREA NETWORKS (WLANS) ARE DISCLOSED. AT LEAST ONE CELLULAR NETWORK, AT LEAST ONE WLAN AND AN IP NETWORK ARE DEPLOYED. A WIRELESS TRANSMIT/RECEIVE UNIT (WTRU) FIRST ESTABLISHES A CONNECTION TO A WLAN (130A) AND A TUNNEL BETWEEN AN ACCESS POINT (AP) AND A PACKET DATA GATEWAY (PDG) IS ESTABLISHED. THE PDG (129) FURTHER ESTABLISHES A TUNNEL TO AN IP NETWORK. THE WTRU (102) THEN INVOKES A SERVICE WHICH IS DELIVERED THROUGH THE WLAN. AS SIGNAL QUALITY FROM THE AP DEGRADES BELOW A PREDETERMINED THRESHOLD, A HANDOVER FROM THE WLAN TO THE CELLULAR NETWORK IS PERFORMED. A NEW CONNECTION TO THE CELLULAR NETWORK MAY BE ESTABLISHED EITHER BEFORE OR AFTER BREAKING THE CURRENT CONNECTION TO THE WLAN (130A) OR THE TWO CONNECTIONS MAY BE MAINTAINED SIMULTANEOUSLY.
Patent MY-150720-A (MY)
Title: Flexible and expandable intravascular stent
Inventor: KADIR ENGR DR MOHAMMED RAFIQ BIN DATO' ABDUL
Filed: 2009-12-29
Abstract: AN EXPANDABLE STENT (10) COMPRISES OF A TUBULAR BODY HAVING A PLURALITY OF ELLIPTICAL BANDS (20), A PLURALITY OF JOINT MEMBERS (30) CONNECTING THE EDGES OF SAID ELLIPTICAL BANDS (20) AND A PLURALITY OF SERPENTINE LINKS (40) CONNECTED TO THE BODIES OF THE ELLIPTICAL BANDS (20), EACH SERPENTINE LINKS (40) COMPRISE A PAIR OF OPPOSITELY ORIENTED CURVES. THE STENT (10) IS RADIALLY EXPANDABLE FROM AN UNDEPLOYED CONDITION IN WHICH THE BODY HAS A FIRST DIAMETER TO A DEPLOYED CONDITION IN WHICH THE BODY HAS A SECOND DIAMETER LARGER THAN THE FIRST DIAMETER. THE EXPANDABLE STENT (10) IS USED AS A MEDICAL DEVICE FOR THE INTRAVASCULAR OR INTRALUMINAL IMPLANTATION. ACCOMPANYING DRAWING:
Patent MY-150488-A (MY)
Title: Method and system for producing artificial skin
Inventor: CHONLADA LEWIS
IPC: A61L27/00
Filed: 2008-06-20
Abstract: RUBBER CAN GENERALLY BE CLASSIFIED INTO NATURAL RUBBER OR SYNTHETIC RUBBER. IN THE FIELD OF MEDICAL SCIENCE, ONE OF THE MORE IMPORTANT PRODUCTS MANUFACTURED FROM SYNTHETIC RUBBER OF IS ARTIFICIAL SKIN. ARTIFICIAL SKIN HAS VARIOUS USES SUCH AS FOR EDUCATIONAL MEDIA, FOR MAKING TRAINING AIDS AND PHANTOMS AND FOR COVERING SURFACES OF PROSTHETIC LIMBS. HOWEVER, IT IS EXPENSIVE TO PRODUCE ARTIFICIAL SKIN FROM SYNTHETIC RUBBER.THE PRESENT INVENTION RELATES TO THE UTILISATION OF NATURAL RUBBER FOR PRODUCING ARTIFICIAL SKIN FOR AT LEAST REDUCING THE COST OF PRODUCING ARTIFICIAL SKIN. A PROCESSING METHOD DESCRIBED ACCORDING TO AN EMBODIMENT OF THE INVENTION IS DISCLOSED. THE PROCESSING METHOD COMPRISES PROVIDING LATEX, ADDING A PEROXIDE AND A PER-COMPOUND TO THE LATEX FOR PROVIDING DEPOLYMERISED LATEX AND COMPOUNDING THE DEPOLYMERISED LATEX FOR PROVIDING COMPOUNDED LATEX WHEREBY THE COMPOUNDED LATEX IS PRE-VULCANISABLE AND SUBSEQUENTLY VULCANISABLE INTO ARTIFICIAL SKIN.
Patent MY-123990-A (MY)
Title: Bar soap composition
Inventor: NASIR ABDUL KARIM BIN MD
IPC: C11D9/38
Filed: 2000-06-02
Abstract: THE INNOVATION RELATES TO A BAR SOAP COMPOSITION, THE SAID COMPOSITION COMPRISING: (A) SURFACTANT COMPONENT WHICH COMPRISES FATTY ACIDS SUCH AS PALM OIL AND PALM KERNEL OIL; (B) ANIMAL FAT SUCH AS GOAT’S MILK FAT; (C) MOITSTURIZER SUCH AS GLYCERINE; AND (D) OTHER INGREDIENTS SUCH AS SKIN CONDITIONER, MILDNESS AID, PERFUME, SOLVENT, COLOURANT, OPACIFIER AND PRESERVATIVE.
Patent OA-11344-A (OA)
Title: Elastomer composite blends and methods for producing them.
Inventor: MABRY MELINDA ANN
IPC: B60C1/00
Filed: 2000-03-29
Abstract: Elastomer composite blends are produced by novel wet/dry mixing methods and apparatus. In the wet mixing step or stage, fluid streams of particulate filler and elastomer latex are fed to the mixing zone of a coagulum reactor to form a mixture in semi-confined flow continuously from the mixing zone through a coagulum zone to a discharge end of the reactor. The particulate filler fluid is fed under high pressure to the mixing zone, such as to form a jet stream to entrain elastomer latex fluid sufficiently energetically to substantially completely coagulate the elastomer with the particulate filler prior to the discharge end. Highly efficient and effective elastomer coagulation is achieved without the need for a coagulation step involving exposure to acid or salt solution or the like. Elastomer composites are produced. Such elastomer composites may be cured or uncured, and combine material properties, such as choice of filler, elastomer, level of filler loading, and macro-dispersion, nor previously achieved. The coagulum produced by such wet mixing step, with or without intermediate processing steps, is then mixed with additional elastomer in a dry mixing step or stage to form elastomer composite blends. The additional elastomer to the coagulum may be the same as or different from the elastomer(s) used in the wet mixing step. <IMAGE>
Patent RU-2000111744-A (RU)
IPC: C12Q1/68
Filed: 2000-05-12
Abstract: DNA sequences encoding a novel intercellular adhesion molecule polypeptide (designated "ICAM-4") and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Molecules that bind to ICAM-4, and uses thereof, are also disclosed.
Patent RU-2001111004-A (RU)
IPC: H05B1/02
Filed: 2000-08-14
Abstract: An electrical resistance or heater of the type comprising a thick film resistive track provided on an insulating substrate has two predetermined sections of said track (8d,8e) with a predetermined current carrying capacity. These sections are bridged by a discrete bridge (22) of an insulating material, e.g. glass, which at a predetermined temperature becomes sufficiently conductive to cause a failure current to flow through one or both of said sections (8d,8e). The resistive track (8) is protected from oxidation by a separate overglaze layer. The heater track section (8d) passing the failure current is provided with means, such as an aperture (24) in the track, for concentrating locally the current flowing therethrough.
Patent RU-2004122421-A (RU)
IPC: H01H47/00
Filed: 2002-12-17
Abstract: The pole contact (C1,C2,C3) wear determination method has an electromagnet (20) with movement controlled by a field coil (21). Wear is determined on the basis of the contact wear stroke produced during a movement closing the electromagnet. An electric signal is measured on the conducting status of a power pole, by measuring the excitation current flowing in the coil on a time basis. The measured wear time is then compared with the initial travel time.
Patent RU-2004122481-A (RU)
IPC: C07D271/10
Filed: 2002-12-20
Abstract: There is provided a series of novel alpha-(N-sulfonamido)acetamide compounds of the Formula (I) wherein R, R1, R2 and R3 are defined herein, which are inhibitors of beta-amyloid peptide (beta-AP) production and are useful in the treatment of Alzheimer's Disease and other conditions affected by anti-amyloid activity.
Patent RU-2006134061-A (RU)
Title: Комбикорм-концентрат для дойных коров
IPC: A23K1/175
Filed: 2006-09-25
Abstract: Гранулированный комбикорм-концентрат для дойных коров, содержащий рожь, шроты, минеральную добавку, премикс, отличающийся тем, в качестве ржи он содержит зерно озимой ржи, в качестве шротов - шроты соевые, подсолнечника или рапсовые, в качестве минеральной добавки - кормовой фосфат и поваренную соль, в качестве премикса - премикс П60-6М и дополнительно содержит жом свекловичный сухой, патоку свекловичную кормовую при следующем содержании компонентов, взятых, мас.%:
Patent RU-2006135203-A (RU)
Title: Диаминопиримидины в качестве антагонистов рецепторов p2x3 и p2x2/3
IPC: C07D417/12
Filed: 2005-02-25
Abstract: 1. Соединение формулы (I):или его фармацевтически приемлемые соли,где:Х представляет собой -СН-; -О-; -СНОН-; -S(O)- или -NR-, где n имеет значения от 0 до 2, и Rпредставляет собой водород или алкил;Y представляет собой водород или -NRR, где один из радикалов Rи Rпредставляет собой водород, а другой представляет собой водород; алкил; циклоалкил; циклоалкилалкил; галогеналкил; галогеналкокси; гидроксиалкил; алкоксиалкил; ацетил; алкилсульфонил; алкилсульфонилалкил; аминокарбонилоксиалкил; гидроксикарбонилалкил; гидроксиалкилоксикарбонилалкил; арил; аралкил; арилсульфонил; гетероарил; гетероарилалкил; гетероарилсульфонил; гетероциклил или гетероциклилалкил;D представляет собой необязательно присутствующий кислород;Rпредставляет собой алкил; алкенил; циклоалкил; циклоалкенил; галоген; галогеналкил; гидроксиалкил или алкокси;R, R, Rи Rкаждый независимо представляет собой водород; алкил; алкенил; амино; галоген; амидо; галогеналкил; алкокси; гидрокси; галогеналкокси; нитро; амино; гидроксиалкил; алкоксиалкил; гидроксиалкокси; алкинилалкокси; алкилсульфонил; арилсульфонил; циано; арил; гетероарил; гетероциклил; гетероциклилалкокси; арилокси; гетероарилокси; аралкилокси; гетероаралкилокси; необязательно замещенный фенокси; -(CH)-(Z)-(CO)-Rили -(CH)-(Z)-SO-(NR)-R, где показатель m и n каждый независимо представляет собой 0 или 1, Z представляет собой О или NR, Rпредставляет собой водород, алкил, гидрокси, алкокси, амино, гидроксиалкил или алкоксиалкил и каждый радикал Rнезависимо представляет собой водород или алкил; или Rи Rмогут вместе образовать алкилендиокси; или Rи Rвместе с атомами, к которым они присоединены, могут образовывать пяти- или шестичлен
Patent RU-2006146280-A (RU)
Title: Глазурь
IPC: C03C8/00
Filed: 2006-12-25
Abstract: 1. Глазурь, содержащая SiO, AlO, BO, NaO, KO, отличающаяся тем, что дополнительно содержит BaO, SrO, ZrOпри следующем соотношении компонентов, мас.%: SiO48,0-50,0; AlO10,0-12,0; BO20,0-25,0; NaO 5,0-7,0; KO 2,0-3,0; BaO 1,0-2,0; SrO 4,0-6,0; ZrO2,0-4,0.2. Глазурь по п.1, отличающаяся тем, что соотношение AlOк SiOсоставляет 1:4-1:5.
Patent RU-2007119448-A (RU)
IPC: C07D487/04
Filed: 2005-10-25
Abstract: A compound of formula (I): wherein the substituents are as defined in the specification as inhibitor of C-Jun N terminal Kinases (JNK) and P-38 Kinases.
Patent RU-2007120571-A (RU)
Title: Способы обеспечения защиты в сетях связи с коммутацией пакетов и устройства для их осуществления
IPC: H04L1/00
Filed: 2005-11-01
Abstract: 1. Способ восстановления кодированного сигнала, передаваемого по линий связи в сети с коммутацией пакетов, содержащий этапы доставки сигнала связи, который был закодирован во множество кадров; определения, какой из указанного множества кадров является основным кадром, потеря которого будет вызывать относительно существенное ухудшение качества, по меньшей мере, одного следующего кадра при декодировании указанного, по меньшей мере, одного следующего кадра; упаковки указанного множества кадров во множество пакетов и определения, какой из пакетов содержит, по меньшей мере, один основной кадр; добавления защищающей информации, по меньшей мере, к одному пакету, который следует за пакетом, отмеченным как пакет, несущий, по меньшей мере, один основной кадр.2. Способ по п.1, в котором указанная защищающая информация обеспечивает возможность в случае, если пакет, несущий, по меньшей мере, один основной кадр, потерян, декодирования и синтеза, по меньшей мере, одного кадра, содержащегося в указанном следующем пакете, с качеством лучшим, чем то качество, которое было бы достигнуто, если бы восстановление проводилось без использования защищающей информации для декодирования и синтеза.3. Способ по п.1, в котором указанный этап определения, какой из указанного множества кадров является основным кадром, содержит определение множества кадров, потеря которых будет вызывать относительно существенное ухудшение качества, по меньшей мере, одного из следующих кадров, когда указанный, по меньшей мере, один следующий кадр декодируется.4. Способ по п.1, в котором указанная защищающая информация содержит информацию, относящуюся к соответс
Patent RU-2007139993-A (RU)
Title: Способ получения раствора ионного серебра и устройство для его осуществления
IPC: A61K33/38
Filed: 2007-10-29
Abstract: 1. Способ получения раствора ионного серебра, заключающийся в использовании металлического серебра и дистиллированной воды с требуемым сопротивлением, в интервале от 0,1 до 18 МОм, отличающийся тем, что дистиллированную воду наливают в химически чистую посуду, нагревают на водяной бане выше 60°С примерно 30 мин, затем в воду погружают электрохимическую ячейку (кассету) ионатора серебра, подключают в цепь постоянного тока, после появления электрической проводимости перемешивают раствор, перемешивание повторяют несколько раз до достижения необходимой концентрации раствора, при этом процесс и консервацию ведут в темноте и с ограничением доступа воздуха. ! 2. Устройство для получения раствора ионного серебра, содержащее электроды из химически чистого серебра, выполненные идентичными по форме и размерам, расположенные параллельно друг другу, заключенные в диэлектрическую перфорированную кассету аналогичной формы и имеющую ручку для помешивания воды в посуде в процессе электролитического растворения серебра, отличающееся тем, что посуда с водой, а также посуда для хранения и кассета с ручкой помещены в емкость, обеспечивающую темноту, и из которой затем откачан воздух, кассета выполнена из стекла, а блок управления и тестер вынесены за пределы емкости. ! 3. Устройство по п.2, отличающееся тем, что емкость выполнена из непрозрачного прочного материала, имеет в верхней части люк с крышкой преимущественно круглой формы, при этом люк и крышка снабжены герметизирующими прокладками, с двух сторон емкости вделаны внутрь резиновые перчатки для правой и левой рук, емкость снабжена ниппелем для откачки воздуха, крышка люка с